DEPLOYDatabase

Person

Dr. Frank Desiere

CEO of CorTec GmbH, a Freiburg-based clinical-stage neurotechnology company developing the Brain Interchange™ implantable brain-computer interface for stroke rehabilitation. Holds a PhD in molecular biology and an MBA, with a background spanning life sciences and global medtech leadership. Led CorTec through its FDA Breakthrough Device designation and the first human implantation of a German-made fully implantable BCI in the United States.

German · 1 current role

Track Dr. Frank Desiere

Physical AI footprint (1)

The physical AI companies Dr. is connected to that DEPLOY verifies. The full record is one click away.

  • CorTecverified→
    CEO

    CorTec is a Freiburg-based clinical-stage neurotechnology company developing the [Brain Interchange](/models/cortec-brain-interchange) BCI system, a fully impla

    1 model

Current roles (1)

Sources (3)

  1. https://www.mobihealthnews.com/news/cortec-becomes-first-german-bci-company-get-fda-breakthrough-designation
  2. CorTec · https://cortec-neuro.com/cortec-welcomes-dr-frank-desiere-as-chief-executive-officer/
  3. Cruxx · https://www.thisiscruxx.com/article/leader-in-the-neurotech-spotlight-frank-desiere-ceo-cor-tec-neuro-board-director-chairman/

Deploy Watch

Track Dr. Frank Desiere on Deploy.

We notify you when a verified role changes, a founded-company event lands, or litigation surfaces.